首页> 外文期刊>Biological & pharmaceutical bulletin >Pyripyropenes, Fungal Sesquiterpenes Conjugated with alpha-Pyrone and Pyridine Moieties, Exhibits Anti-angiogenic Activity against Human Umbilical Vein Endothelial Cells
【24h】

Pyripyropenes, Fungal Sesquiterpenes Conjugated with alpha-Pyrone and Pyridine Moieties, Exhibits Anti-angiogenic Activity against Human Umbilical Vein Endothelial Cells

机译:吡喃戊二烯,真菌倍半萜与α-吡喃酮和吡啶部分结合,表现出对人脐静脉内皮细胞的抗血管生成活性。

获取原文
获取原文并翻译 | 示例
       

摘要

In the course of our search for anti-angiogenic substances, pyripyropenes A (1), B (2), and D (3) were rediscovered as selective anti-proliferative substances against human umbilical vein endothelial cells (HUVECs) from a marine-derived fungus of Aspergillus sp. Pyripyropenes showed potent anti-proliferative activity against HUVECs with IC50 values of the range of 0.1-1.8 mu M, which were cytostatic at 0.05 to 20 mu M. The selective index was more than 55-fold in comparison with those of several tumor cell lines. Compound I inhibited vascular endothelial growth factor (VEGF)-induced migration and tubular formation of HUVECs, while I showed no effect on the VEGF-induced phosphorylations of extracellular signal-regulated kinase (ERK)1/2, p38, and Akt. Pyripyropenes were originally isolated as an inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT-2). While, the expression level of ACATs between HUVECs and other tumor cell lines did not correspond to the selective index of the anti-proliferative activity of compound 1. Moreover, ACATs inhibitor, 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976), showed growth inhibitory activity with only poor selectivity (2.4-fold) between HUVECs and human epidermoid carcinoma KB3-1 cells.
机译:在我们寻找抗血管生成物质的过程中,从海洋来源的人脐静脉内皮细胞(HUVECs)中重新发现了吡咯烷A(1),B(2)和D(3)作为选择性抗增殖物质。曲霉菌。吡咯烷酮对HUVEC表现出有效的抗增殖活性,IC50值在0.1-1.8μM范围内,在0.05至20μM时具有抑制细胞生长的作用。与几种肿瘤细胞系相比,选择性指数高55倍以上。化合物I抑制血管内皮生长因子(VEGF)诱导的HUVEC迁移和肾小管形成,而化合物I对VEGF诱导的细胞外信号调节激酶(ERK)1/2,p38和Akt磷酸化没有影响。吡咯烷酮最初是作为酰基辅酶A抑制剂:胆固醇酰基转移酶(ACAT-2)分离的。同时,HUVEC与其他肿瘤细胞系之间ACAT的表达水平与化合物1的抗增殖活性的选择指数不符。此外,ACAT抑制剂2,2-二甲基-N-(2,4,6 -三甲氧基苯基)十二碳酰胺(CI-976)在HUVEC和人表皮样癌KB3-1细胞之间显示出抑制生长的活性,选择性差(2.4倍)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号